Optic neuritis has been observed in patients receiving rituximab for neurologic autoimmune disorders such as myelin oligodendrocyte glycoprotein antibody-associated disease (MOG AD), but is exceedingly rare in cancer patients (59). The gene discussed is OMG; the disease is Alzheimer disease.